Whitehawk Therapeutics, Inc

WHWKNASDAQ · Pharmaceutical Preparations

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

57.0M

on 2026-06-30, from 24.6M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

None

No S-3 or F-3 shelf on file in the last 30 months.

$75.0M

TD Securities (USA), agreement of 2022-03-17. No at-the-market sales statement read from a 10-Q or 10-K. 424B5 ↗

Warrants

29K

Warrants of every class as tagged in the XBRL facts on 2024-09-30. 10-Q ↗

Cash

11 quarters

$190.0M on 2026-06-30 ÷ $17.3M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
Date	What	Shares	Price	Gross	Filing
2026-05-12	Private placement	4,330,866	$3.92	not stated	8-K ↗
2025-03-04	Private placement incl. 20.08M pre-funded	41,668,500	$2.40	not stated	8-K ↗